Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT06122779 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: BMS-986435
OTHER: Placebo

Sponsor

Bristol-Myers Squibb